Provided by Tiger Fintech (Singapore) Pte. Ltd.

MaxCyte Inc

2.84
+0.03001.07%
Post-market: 2.840.00000.00%16:10 EDT
Volume:429.37K
Turnover:1.22M
Market Cap:301.93M
PE:-7.25
High:2.89
Open:2.82
Low:2.78
Close:2.81
Loading ...

MaxCyte Shares Surge On Boost to Revenue-Growth Outlook

Dow Jones
·
10 Dec 2024

MaxCyte’s Strategic Growth and Cost Efficiency Drive Buy Rating

TIPRANKS
·
10 Dec 2024

MaxCyte to reduce workforce by 15% following internal review

TIPRANKS
·
09 Dec 2024

MaxCyte raises FY24 core business revenue view to 6%-8% from flat to up 5%

TIPRANKS
·
09 Dec 2024

MaxCyte Reduces 15% of Workforce, Raises 2024 Revenue Guidance

MT Newswires Live
·
09 Dec 2024

BRIEF-Maxcyte Announces Streamlined Operations And Raises 2024 Revenue Guidance

Reuters
·
09 Dec 2024

MaxCyte, Inc. MaxCyte, Inc. - Mxcr - MaxCyte Streamlines Operations and Raises Guidance

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Inc - Cuts 21 Positions, 15% of Global Workforce

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Inc - Expects $5.8 Million Cost Savings in 2025

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Inc - Raises 2024 Core Revenue Guidance to 6%-8% Growth

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Inc: Raising Its Full-Year 2024 Core Revenue Guidance to Project 6% to 8% Growth Compared to 2023

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

THOMSON REUTERS
·
09 Dec 2024

MaxCyte Announces Streamlined Operations and Raises 2024 Revenue Guidance

GlobeNewswire
·
09 Dec 2024

MaxCyte’s Voting Rights Shift with BlackRock Acquisition

TIPRANKS
·
28 Nov 2024

This MaxCyte Insider Increased Their Holding In The Last Year

Simply Wall St.
·
21 Nov 2024

MaxCyte Celebrates 25 Years of Innovation Driving Cell Engineering-Based Therapeutics

GlobeNewswire
·
13 Nov 2024

MaxCyte Inc (MXCT) Q3 2024 Earnings Call Highlights: Strong Core Revenue Growth Amidst Market ...

GuruFocus.com
·
08 Nov 2024

Stifel Nicolaus Keeps Their Buy Rating on MaxCyte (MXCT)

TIPRANKS
·
07 Nov 2024

MaxCyte’s Revenue Grows and Strategic Moves Unveiled

TIPRANKS
·
07 Nov 2024

MaxCyte Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024